Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
EMD Serono
EMD Serono
Seagen Inc.
Seagen Inc.
Eli Lilly and Company
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
Genentech, Inc.
AstraZeneca
Bristol-Myers Squibb
Eli Lilly and Company
OncoC4, Inc.
Exscientia AI Limited
KaliVir Immunotherapeutics
Fate Therapeutics
Arcus Biosciences, Inc.
IDEAYA Biosciences
Sotio Biotech Inc.
Radiopharm Theranostics, Ltd
AstraZeneca
GlaxoSmithKline
Terremoto Biosciences Inc.
Taiho Oncology, Inc.
Ensem Therapeutics
Merck Sharp & Dohme LLC
Mayo Clinic
Eli Lilly and Company
Neonc Technologies, Inc.
Pfizer
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Exscientia AI Limited
Daiichi Sankyo
Normunity AccelCo, Inc.
Poseida Therapeutics, Inc.
DualityBio Inc.
MacroGenics
Amgen
SystImmune Inc.
Grey Wolf Therapeutics
Xinqiao Hospital of Chongqing
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
Dren Bio
Novartis
Brigham and Women's Hospital
Elephas
OncoNano Medicine, Inc.